UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 981

Sortiert nach

The Future of Nuclear Medicine, Molecular Imaging, and Theranostics

Journal of Nuclear Medicine, 2020-12, Vol.61 (Suppl 2), p.263S-272S

2020

Volltextzugriff (PDF)

Targeted Brain Tumor Radiotherapy Using an Auger Emitter

Clinical cancer research, 2020-06, Vol.26 (12), p.2871-2881

2020

Volltextzugriff (PDF)

Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer

Proceedings of the National Academy of Sciences - PNAS, 2015-12, Vol.112 (52), p.15850-15855

2015

Volltextzugriff (PDF)

CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma

Genes & development, 2014-08, Vol.28 (16), p.1800-1814

2014

Volltextzugriff (PDF)

Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses

Journal of Nuclear Medicine, 2016-03, Vol.57 (3), p.453-459

2016

Volltextzugriff (PDF)

Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation

Cancer research (Chicago, Ill.), 2015-11, Vol.75 (22), p.4688-4696

2015

Volltextzugriff (PDF)

Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers

Proceedings of the National Academy of Sciences - PNAS, 2023-04, Vol.120 (14), p.e2220413120-e2220413120

2023

Volltextzugriff (PDF)

Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (14), p.3931-3941

2017

Volltextzugriff (PDF)

Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer

Science signaling, 2014-03, Vol.7 (318), p.ra29

2014

Volltextzugriff (PDF)

Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology

Journal of Nuclear Medicine, 2013-11, Vol.54 (11), p.1876-1882

2013

Volltextzugriff (PDF)

Radiotheranostics in oncology: current challenges and emerging opportunities

Nature reviews. Clinical oncology, 2022-08, Vol.19 (8), p.534-550

2022

Volltextzugriff (PDF)

A Novel Technology for the Imaging of Acidic Prostate Tumors by Positron Emission Tomography

Cancer research (Chicago, Ill.), 2009-05, Vol.69 (10), p.4510-4516

2009

Volltextzugriff (PDF)

Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2014-05, Vol.111 (20), p.7254-7259

2014

Volltextzugriff (PDF)

Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma

Clinical cancer research, 2019-01, Vol.25 (2), p.868-880

2019

Volltextzugriff (PDF)

Cerenkov luminescence imaging of medical isotopes

Journal of Nuclear Medicine, 2010-07, Vol.51 (7), p.1123-1130

2010

Volltextzugriff (PDF)

Click Here for Better Chemistry

The New England journal of medicine, 2022-12, Vol.387 (24), p.2291-2293

2022

Volltextzugriff (PDF)

89Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection

The Journal of nuclear medicine (1978), 2017-09, Vol.58 (9), p.1386-1394

2017

Volltextzugriff (PDF)

Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants

The Journal of nuclear medicine (1978), 2016-11, Vol.57 (11), p.1811-1816

2016

Volltextzugriff (PDF)

α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1

Journal of Nuclear Medicine, 2018-06, Vol.59 (6), p.878-884

2018

Volltextzugriff (PDF)

Oncology-Inspired Treatment Options for COVID-19

Journal of Nuclear Medicine, 2020-12, Vol.61 (12), p.1720-1723

2020

Volltextzugriff (PDF)

Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines

Chemical communications (Cambridge, England), 2019-01, Vol.55 (10), p.1394-1397

2019

Volltextzugriff (PDF)

α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 2

Journal of Nuclear Medicine, 2018-07, Vol.59 (7), p.1020-1027

2018

Volltextzugriff (PDF)

A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry

Journal of Nuclear Medicine, 2013-08, Vol.54 (8), p.1389-1396

2013

Volltextzugriff (PDF)

The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals

Journal of Nuclear Medicine, 2013-06, Vol.54 (6), p.829-832

2013

Volltextzugriff (PDF)

Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system

The Journal of nuclear medicine (1978), 2011-04, Vol.52 (4), p.625-633

2011

Volltextzugriff (PDF)

1 – 25 von 981

Suche als RSS-Feed

Aktive Filter

PublikationsformTagungsberichte

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(917)
Mit Volltextzugriff
(791)

Publikationsform

Sprache

Englisch
(955)
Japanisch
(114)

Erscheinungsjahr

n.n

Thema

Science & Technology
(497)
Life Sciences & Biomedicine
(418)
Humans
(387)
Female
(212)
Male
(202)
Animals
(155)
Middle Aged
(111)
Adult
(109)
Biological And Medical Sciences
(109)
Aged
(104)
Mice
(101)
Medical Sciences
(94)
Tumors
(84)
Oncology
(63)
Science & Technology - Other Topics
(60)
Cell Line, Tumor
(59)
Multidisciplinary Sciences
(59)
General & Internal Medicine
(55)
Patients
(54)
Cancer
(53)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

The Future of Nuclear Medicine, Molecular Imaging, and Theranostics

Targeted Brain Tumor Radiotherapy Using an Auger Emitter

Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer

CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma

Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses

Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation

Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers

Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer

Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer

Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology

Radiotheranostics in oncology: current challenges and emerging opportunities

A Novel Technology for the Imaging of Acidic Prostate Tumors by Positron Emission Tomography

Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer

Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma

Cerenkov luminescence imaging of medical isotopes

Click Here for Better Chemistry

89Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection

Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants

α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1

Oncology-Inspired Treatment Options for COVID-19

Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines

α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 2

A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry

The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals

Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system

Aktive Filter

Suchergebnisse filtern